TrialThe journal of prevention of Alzheimer's disease2024

Phase 2A Learnings Incorporated into RewinD-LB, a Phase 2B Clinical Trial of Neflamapimod in Dementia with Lewy Bodies.

N D Prins et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.